Description
Cytotoxicity assessment of Andrographis (EAM) and Echinacea (ESN) extracts on host cell lines demonstrates the concentration range at which the extracts remain non-toxic. Cell viability remains above 80% at the tested therapeutic concentrations.
Figure 2
ChartSource Paper
Inhibition of Human Respiratory Influenza A Virus and Human Betacoronavirus-1 by the Blend of Double-Standardized Extracts of Aronia melanocarpa (Michx.) …Cite This Figure
![Figure 2: Cytotoxicity assessment of Andrographis (EAM) and Echinacea (ESN) extracts on host cell lines demonstrates the concentration range at which the extracts remain non-toxic. Cell viability remains above 80% at the tested therapeutic concentrations.]() > Source: Michał Ochnik et al. "Inhibition of Human Respiratory Influenza A Virus and Human Betacoronavirus-1 by." *Pharmaceuticals (Basel, Switzerland)*, 2022. PMID: [35631445](https://pubmed.ncbi.nlm.nih.gov/35631445/)
<figure> <img src="" alt="Cytotoxicity assessment of Andrographis (EAM) and Echinacea (ESN) extracts on host cell lines demonstrates the concentration range at which the extracts remain non-toxic. Cell viability remains above 80% at the tested therapeutic concentrations." /> <figcaption>Figure 2. Cytotoxicity assessment of Andrographis (EAM) and Echinacea (ESN) extracts on host cell lines demonstrates the concentration range at which the extracts remain non-toxic. Cell viability remains above 80% at the tested therapeutic concentrations.<br> Source: Michał Ochnik et al. "Inhibition of Human Respiratory Influenza A Virus and Human Betacoronavirus-1 by." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35631445/">35631445</a></figcaption> </figure>